NIOSHTIC-2 Publications Search
Pattern of response of intact drosophila to known teratogens.
Schuler RL; Radike MA; Hardin BD; Niemeier RW
J Amer Coll Toxicol 1985 Jul; 4(4):291-303
The response of intact Drosophila-fruit-flies to known teratogens was evaluated. Seventeen chemicals were tested. Fly larvae were treated over their entire morphogenic cycle by adding each test chemical to the culture medium. Eggs were deposited by untreated females on the surface of the medium and hatched, and the emerging larvae immediately began to feed. After several days these larvae metamorphosed into adult flies. The incidence of abnormalities among exposed flies was compared with the incidence in control flies. An increased incidence of 14 kinds of abnormalities occurred in flies that were treated with the test chemicals. Although there was a variety of responses, each chemical tested elicited a unique and reproducible pattern of abnormalities that appeared generally to be dose related. For example, vincristine-sulfate (2068782), 5- fluorouracil (51218), and methotrexate (59052) induced eye defects. Vincristine-sulfate caused a bulging or rippling of eye tissue. 5- Fluorouracil reduced the size of the eye. Methotrexate disrupted the anterior half of the eye surface. Of the tested chemicals, only colchicine (64868), coumarin (91645), and ethanol (64175) produced weak responses. The only positive response to colchicine was a significant reduction in bristle size in three of nine flies. Ethanol increased slightly the incidence of abdominal irregularities. The authors suggest that since Drosophila appears to be resistant to ethanol, ethanol may be a reasonable choice as an aid in solubilizing test chemicals for incorporation into the medium. Drosophila may have the potential to be a valuable teratogen screen. Additional studies, especially with nonteratogenic substances, are necessary.
NIOSH-Author; Teratology; Organic-chemicals; Laboratory-animals; In-vivo-studies; Teratogenesis; Biological-effects; Morphology; Dose-response; Alcohols; Antineoplastic-agents
R. L. Schuler, Department of Health and Human Services, Centers for Disease Control, National Institute for Occupational Safety and Health, Division of Biomedical and Behavioral Science, Robert A. Taft Laboratories, Cincinnati, Ohio
2068-78-2; 51-21-8; 59-05-2; 64-86-8; 91-64-5; 64-17-5
Issue of Publication
Journal of the American College of Toxicology
Page last reviewed: September 2, 2020
Content source: National Institute for Occupational Safety and Health Education and Information Division